Upstream Bio, Inc.
NASDAQ:UPBBiotechnology
+$0.10 today
- Market cap
- $114.01M
- Beta
- 1.11
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$2.89
Volume 1.24M
Average 0.66M
UPB Other Non-current Assets
Long-term assets not reported separately.
Upstream Bio, Inc.NASDAQ: UPB
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets broadly unchanged from a year ago
Other non-current assets stood at $194K at the end of Q1 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +202.6% a year.
Context
- Other non-current assets amounted to 0.1% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other non-current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 194K USD
- Year-over-year change
- +0.0%
- 3-year CAGR
- +202.6%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 194K | +0.0% |
| FY2024 | 2024-12-31 | 194K | +19400100.0% |
| FY2023 | 2023-12-31 | (1) | -100.0% |
| FY2022 | 2022-12-31 | 7K | — |
Other Non-current Assets vs competitors
How UPB compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +0.0% is the 4th highest of 8, against a peer median of -27.2%.
- Other non-current assets amounts to 0.1% of total assets for UPB, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $141.26M USD | +742.5% | — | 18.6% | |
| Mar 2026 | $15.95M USD | -27.2% | -15.7% | 1.5% | |
| Mar 2026 | $15.06M USD | +17.2% | +47.1% | 2.0% | |
| Sep 2026 | $3.5M USD | +39.9% | +43.2% | 0.4% | |
| Mar 2026 | $386K USD | -90.9% | -83.7% | 0.1% | |
UPBUpstream Bio, Inc. | Mar 2026 | $194K USD | +0.0% | +202.6% | 0.1% |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| Sep 2026 | €0 EUR | — | — | 0.0% | |
| Mar 2026 | $0 USD | -100.0% | -52.0% | 0.0% | |
| Peer median (excluding UPB) | — | -27.2% | -15.7% | 0.1% | |
Competitors are the stored peer set for UPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Upstream Bio, Inc.
NASDAQ:UPB
Intrinsic Alpha fair value
Locked
Current Price
$2.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.